# A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function

> **NCT00759564** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 29 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** CP-70,429 and PF-03709270

## Key facts

- **NCT ID:** NCT00759564
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2016-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759564, "A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00759564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*